MedDataX Logo

A Post Marketing Surveillance Study On Pregabalin (Lyrica) On Efficacy, Safety And Tolerability Of Pregabalin

NCT ID: NCT00892008

Last Updated: 2021-01-25

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2278 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-09-30

Study Completion Date

2008-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is being conducted as a regulatory requirement post initial marketing authorization. This is primarily a safety study. This was an open label study and patients were enrolled once the decision to prescribe the medication was made by the Investigator.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Symptomatic Treatment Of Patients With Neuropathic Pain With LYRICA

NCT00843284

Neuropathic Pain
COMPLETED

Safety And Efficacy Of Lyrica (Regulatory Post Marketing Commitment Plan)

NCT01256593

Neuralgia
COMPLETED

Lyrica (Pregabalin) Korean Post Marketing Surveillance Study

NCT01220180

Epilepsy Neuropathic Pain Fibromyalgia +1 more
COMPLETED

Safety And Efficacy In Long Term Use Of Lyrica (Regulatory Post Marketing Commitment Plan)

NCT01279850

Neuropathic Pain
COMPLETED

A Study to Evaluate the Efficacy and Safety of Pregabalin (Lyrica) for the Treatment of Nerve Pain

NCT00631943

Neuralgia
COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neuropathic Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Open-Label

This study was open-label with only one treatment group. Pregabalin was prescribed in accordance with usual clinical practice.

Pregabalin

Intervention Type DRUG

Pregabalin 75-150 mg BID for at least 2 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pregabalin

Pregabalin 75-150 mg BID for at least 2 weeks.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Lyrica

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female, 18 years old and above diagnosed with neuropathic pain.

Exclusion Criteria

* Patients that are pregnant and lactating; and patients with known hypersensitivity to pregabalin or its related components.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pfizer CT.gov Call Center

Role: STUDY_DIRECTOR

Pfizer

Related Links

Access external resources that provide additional context or updates about the study.

https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A0081094&StudyName=A%20Post%20Marketing%20Surveillance%20Study%20On%20Pregabalin%20%28Lyrica%29%20On%20Efficacy%2C%20Safety%20And%20Tolerability

To obtain contact information for a study center near you, click here.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

A0081094

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Safety and Efficacy Evaluation Of Pregabalin (Lyrica) With Patients With Generalized Anxiety Disorder
NCT00624780 COMPLETED PHASE4
Pregabalin for Treatment of Patients With Postherpetic Neuralgia (PHN)
NCT01455428 COMPLETED PHASE4
Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy
NCT01332149 COMPLETED PHASE3
Study of Pregabalin in the Prevention of Central Neuropathic Pain in Acute Spinal Cord Injury
NCT00879021 TERMINATED PHASE3
A Study to Assess the Efficacy, Safety and Tolerability of Pregabalin in Patients With Symptoms of Neuropathic Pain
NCT00301223 COMPLETED PHASE3
A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin In Patients With Fibromyalgia
NCT00830128 COMPLETED PHASE3
A Study To Assess The Ability Of A Crossover Study Design To Detect The Efficacy Of Pregabalin In Post-Traumatic Neuropathic Pain Patients
NCT00654940 COMPLETED PHASE1
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
NCT01057693 COMPLETED PHASE3
Efficacy Study Measuring the Impact of Pregabalin on Peripheral Neuropathic Pain.
NCT00219544 COMPLETED PHASE3
Trial of Efficacy and Safety of Pregabalin in Subjects With Neuropathic Pain Associated With Lumbo-Sacral Radiculopathy
NCT00159705 COMPLETED PHASE3
A Study of the Efficacy and Safety of Pregabalin for the Treatment of Diabetic Peripheral Neuropathy or Postherpetic Neuralgia
NCT00629681 COMPLETED PHASE4
Primary Care Identification Of Patients With Chronic Neuropathic Low Back Pain Study
NCT01298466 WITHDRAWN PHASE4
PROs in Chronic Low Back Pain Patients With Accompanying Lower Limb Pain (Neuropathic Component) Treated With Pregabalin
NCT02273908 COMPLETED
Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Chronic Neuropathic Pain.
NCT00141362 COMPLETED PHASE3
Pilot Study Of Pregabalin And Prediction Of Treatment Response In Patients With Postherpetic Neuralgia
NCT01603394 TERMINATED PHASE4
Effects Of Pregabalin (Lyrica) On Sleep Maintenance In Subjects With Fibromyalgia
NCT00883740 COMPLETED PHASE3
A Safety Study Of Pregabalin In Fibromyalgia
NCT00282997 COMPLETED PHASE3
A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Postherpetic Neuralgia
NCT00394901 COMPLETED PHASE3
A Study of Lyrica as Treatment for Sleep Problems in Patients With Sleep Problems and Seizures
NCT00643136 COMPLETED PHASE3
Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia
NCT01270828 COMPLETED PHASE3
A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy
NCT00553280 COMPLETED PHASE3
Pregabalin Trial In HIV Neuropathic Pain
NCT01145417 TERMINATED PHASE3
Determine Long-Term Safety and Tolerability of Pregabalin in Patients With Anxiety Disorders.
NCT00150449 COMPLETED PHASE3
A Study For Pregabalin In Patients With Fibromyalgia
NCT01387607 COMPLETED PHASE3
Pregabalin (Lyrica) for the Treatment of Essential Tremor
NCT00584376 COMPLETED PHASE4